Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Mey

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Swiss Medical Weekly|May 23, 2015
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
British Journal of Haematology|April 26, 2002
Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiologyMarcus Gorschlüter, Günter Marklein, Katja Höfling, et al.
Swiss Medical Weekly|April 4, 2019
Updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Swiss Medical Weekly|July 26, 2018
Diagnosis and treatment of follicular lymphoma: an updateMario Bargetzi, Reto Baumann, Sergio Cogliatti, et al.
British Journal of Haematology|March 29, 2016
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08Felicitas Hitz, Emanuele Zucca, Thomas Pabst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, et al.
Blood|September 22, 2018
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myelomaChristoph Driessen, Rouven Müller, Urban Novak, et al.
Hemasphere|February 8, 2021
Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-upMeletios A Dimopoulos, Philippe Moreau, Evangelos Terpos, et al.
Swiss Medical Weekly|October 23, 2025
Updated recommendations for diagnosis and treatment of multiple myeloma in SwitzerlandMartina Bertschinger, Holger W Auner, Veronika Ballova, et al.
Human Gene Therapy|April 15, 2003
Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinomaAngela Märten, Sabine Renoth, Thomas Heinicke, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Swiss Medical Weekly|May 23, 2015
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
British Journal of Haematology|April 26, 2002
Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiologyMarcus Gorschlüter, Günter Marklein, Katja Höfling, et al.
Swiss Medical Weekly|April 4, 2019
Updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Swiss Medical Weekly|July 26, 2018
Diagnosis and treatment of follicular lymphoma: an updateMario Bargetzi, Reto Baumann, Sergio Cogliatti, et al.
British Journal of Haematology|March 29, 2016
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08Felicitas Hitz, Emanuele Zucca, Thomas Pabst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, et al.
Blood|September 22, 2018
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myelomaChristoph Driessen, Rouven Müller, Urban Novak, et al.
Hemasphere|February 8, 2021
Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-upMeletios A Dimopoulos, Philippe Moreau, Evangelos Terpos, et al.
Swiss Medical Weekly|October 23, 2025
Updated recommendations for diagnosis and treatment of multiple myeloma in SwitzerlandMartina Bertschinger, Holger W Auner, Veronika Ballova, et al.
Human Gene Therapy|April 15, 2003
Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinomaAngela Märten, Sabine Renoth, Thomas Heinicke, et al.
Pageof 6